- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Telangana Minister K T Rama Rao inaugrates Ferring Pharma Genome Valley facility
Anindya Ghosh, Managing Director, Ferring Laboratories Private Limited said, " this site in Hyderabad is an integrated facility with R&D and manufacturing capability. The manufacturing facility is mainly designed for oral solid dosage form."
Hyderabad: Telangana Minister for Information Technology and Industries K T Rama Rao inaugurated the Ferring Pharmaceuticals facility at Genome Valley here on Monday established with a total investment of about 30 Million Euros.
The facility will employ around 110 people. Headquartered in Saint-Prex, Switzerland, the pharmaceutical company specializes in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years and has a portfolio covering treatments from conception to birth.
Speaking on the occasion, Rama Rao, while congratulating Ferring Pharma said, "We are extremely happy to welcome Ferring Pharmaceuticals, which is a global biopharmaceutical group, having about 12 R&D Centers and 13 Manufacturing Sites across the globe. This facility is truly state-of-the-art with unique capabilities in formulation development, packaging development and analytical development, the Minister said the company will focus on developing and manufacturing urology products".
Francois Hosotte, Vice President Strategic Projects & Engineering, Ferring Pharmaceuticals said, in pursuit of our mission to become a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology we have invested 18 percent of our 2B euros Revenue in R&D.
Ferring harnesses its world-class competencies in science and business with other innovative technologies to create solutions for patients and doctors, he said this campus is a living embodiment of our mission.
This campus is bringing together Development and Production activities in two separate buildings, Hosotte added.
Anindya Ghosh, Managing Director, Ferring Laboratories Private Limited (Ferring Pharmaceuticals) said, "this Site in Hyderabad is an integrated facility with R&D and Manufacturing capability. The R&D capability includes Formulation Development, Packaging Development and Analytical Development. The Manufacturing facility is mainly designed for Oral Solid Dosage Form.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751